RE:RE:Additions to Study DesignI think this is good. The trial still ends at 450 days past initial response, but Theralase will continue to compile durable response data. I don't think any prospective treatment we've heard about so far will be able to compete with Ruvidar PDT's durable response and Theralase will have the data to prove it.
Oilminerdeluxe wrote: Ungodly frustrating. But what can you do? Hope we get a nice update whenever it arrives.